YU54499A - Farmaceutski preparat za primenu na mukozu - Google Patents
Farmaceutski preparat za primenu na mukozuInfo
- Publication number
- YU54499A YU54499A YU54499A YU54499A YU54499A YU 54499 A YU54499 A YU 54499A YU 54499 A YU54499 A YU 54499A YU 54499 A YU54499 A YU 54499A YU 54499 A YU54499 A YU 54499A
- Authority
- YU
- Yugoslavia
- Prior art keywords
- mucosa
- application
- preparation
- pharmaceutic
- medicament
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0043—Nose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/16—Otologicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/18—Drugs for disorders of the endocrine system of the parathyroid hormones
- A61P5/22—Drugs for disorders of the endocrine system of the parathyroid hormones for decreasing, blocking or antagonising the activity of calcitonin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/02—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
- A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
- A61K47/186—Quaternary ammonium compounds, e.g. benzalkonium chloride or cetrimide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
- A61K47/38—Cellulose; Derivatives thereof
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Epidemiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Diabetes (AREA)
- Physical Education & Sports Medicine (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Hematology (AREA)
- Otolaryngology (AREA)
- Endocrinology (AREA)
- Rheumatology (AREA)
- Biomedical Technology (AREA)
- Toxicology (AREA)
- Neurosurgery (AREA)
- Immunology (AREA)
- Pulmonology (AREA)
- Obesity (AREA)
- Emergency Medicine (AREA)
- Neurology (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Steroid Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Materials For Medical Uses (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Abstract
Predmetni pronalazak obezbedjuje farmaceutski preparat za primenu na mukozu koji se primenjuje u terapiji lekom koji obuhvata vodeno-nerastvornu i/ili slabo rastvornu supstancu, medikament i vodenu sredinu i koji ima osmotski pritisak manji od 290 mOsm. Ovaj preparat je bolji od uobičajenih farmaceutskih preparata za primenu na mukozu, usled svoje efikasnosti i visoke propustljivosti u krv na mukozi. Predmetni pronalazak dalje obezbedjuje farmaceutski preparat za primenu na mukozu koji obuhvata hemostatički agens i medikament. Ovaj preparat je bolji od uobičajenih farmaceutskih preparata za primenu na mukozu usled svoje propustljivosti i zadržavanja na mukozi.[Subject of the invention ensures pharmaceutical preparation for application to mucosa applied in the therapy by medication involving water-insoluble and/or slightly resolved substance, medicament and water medium environment that has osmotic pressure less than 290 mOsm. This preparation is better than the usual pharmaceutic preparations applied to mucosa, due to its efficiency and high absorption into blood of mucosa. Subject to the invention further secures pharmaceutic preparation for application to mucosa including homeostatic agent and medicament. The preparation is better than the usual pharmaceutic preparations for application to mucosa due to its permeability and keep on mucosa.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP11088798 | 1998-04-21 | ||
JP11088898 | 1998-04-21 |
Publications (2)
Publication Number | Publication Date |
---|---|
YU54499A true YU54499A (sh) | 2002-06-19 |
RS49764B RS49764B (sr) | 2008-04-04 |
Family
ID=26450407
Country Status (36)
Country | Link |
---|---|
US (3) | US6939559B1 (sh) |
EP (1) | EP0998916B1 (sh) |
JP (2) | JP5142420B2 (sh) |
KR (1) | KR100686901B1 (sh) |
CN (1) | CN1304052C (sh) |
AT (1) | ATE336986T1 (sh) |
AU (1) | AU757772B2 (sh) |
BG (1) | BG64919B1 (sh) |
BR (1) | BRPI9906372B8 (sh) |
CA (1) | CA2294457C (sh) |
CY (1) | CY1105771T1 (sh) |
CZ (1) | CZ298466B6 (sh) |
DE (1) | DE69932905T2 (sh) |
DK (1) | DK0998916T3 (sh) |
EA (1) | EA002967B1 (sh) |
EE (1) | EE05072B1 (sh) |
ES (1) | ES2272064T3 (sh) |
GE (1) | GEP20022669B (sh) |
GT (2) | GT199900180AA (sh) |
HR (1) | HRP990402C1 (sh) |
HU (1) | HU226712B1 (sh) |
ID (1) | ID24818A (sh) |
IL (1) | IL133614A (sh) |
IS (1) | IS2453B (sh) |
NO (1) | NO328270B1 (sh) |
NZ (1) | NZ501950A (sh) |
PL (1) | PL197875B1 (sh) |
PT (1) | PT998916E (sh) |
RS (1) | RS49764B (sh) |
SI (1) | SI0998916T1 (sh) |
SK (1) | SK286101B6 (sh) |
TR (1) | TR199903193T1 (sh) |
TW (1) | TWI243687B (sh) |
UA (1) | UA77640C2 (sh) |
WO (1) | WO1999053899A1 (sh) |
ZA (1) | ZA997727B (sh) |
Families Citing this family (29)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6261836B1 (en) * | 1996-10-01 | 2001-07-17 | Geron Corporation | Telomerase |
AR026073A1 (es) | 1999-10-20 | 2002-12-26 | Nycomed Gmbh | Composicion farmaceutica acuosa que contiene ciclesonida |
AR026072A1 (es) | 1999-10-20 | 2002-12-26 | Nycomed Gmbh | Composicion farmaceutica que contiene ciclesonida para aplicacion a la mucosa |
ES2348034T3 (es) * | 2002-08-30 | 2010-11-29 | Nycomed Gmbh | Uso de la combinacion de ciclesonida y antihistaminas para el tratamiento de la rinitis alergica. |
AU2003289011A1 (en) * | 2002-12-10 | 2004-06-30 | Showa Yakuhin Kako Co., Ltd. | Composition for topical anesthesia |
WO2004052374A1 (en) * | 2002-12-12 | 2004-06-24 | Altana Pharma Ag | Combination medicament |
US20050025825A1 (en) | 2003-07-31 | 2005-02-03 | Xanodyne Pharmacal, Inc. | Tranexamic acid formulations with reduced adverse effects |
DK1670482T4 (da) * | 2003-09-16 | 2022-08-22 | Covis Pharma B V | Anvendelse af ciclesonid til behandlingen af respiratoriske sygdomme |
PE20050941A1 (es) | 2003-12-16 | 2005-11-08 | Nycomed Gmbh | Suspensiones acuosas de ciclesonida para nebulizacion |
JP4128521B2 (ja) * | 2003-12-19 | 2008-07-30 | 信越化学工業株式会社 | ゲル状シート及びその製造方法 |
US7947739B2 (en) | 2004-03-04 | 2011-05-24 | Ferring B.V. | Tranexamic acid formulations |
US20050244495A1 (en) | 2004-03-04 | 2005-11-03 | Xanodyne Pharmaceuticals, Inc. | Tranexamic acid formulations |
US20090215898A1 (en) | 2004-03-04 | 2009-08-27 | Xanodyne Pharmaceuticals, Inc. | Tranexamic acid formulations |
US8022106B2 (en) | 2004-03-04 | 2011-09-20 | Ferring B.V. | Tranexamic acid formulations |
CA2563556C (en) * | 2004-04-20 | 2013-01-29 | Altana Pharma Ag | Use of ciclesonide for the treatment of respiratory diseases in a smoking patient |
DE602005015506D1 (de) * | 2004-04-28 | 2009-09-03 | Shinetsu Chemical Co | Filmzubereitung und Verfahren zu deren Herstelllung |
US20070231396A1 (en) * | 2006-03-29 | 2007-10-04 | Ray Charles D | Medication spray formulation |
CA2717984C (en) * | 2008-03-14 | 2013-11-26 | Cephalon, Inc. | Enhanced transmucosal composition and dosage form |
ES2657686T3 (es) * | 2009-06-24 | 2018-03-06 | Lipoid Gmbh | Composición para aplicaciones cosméticas, farmacéuticas o dietéticas |
WO2011135585A2 (en) | 2010-04-28 | 2011-11-03 | Cadila Healthcare Limited | Aqueous pharmaceutical solution of ciclesonide |
US9504736B2 (en) | 2010-09-23 | 2016-11-29 | The Regents Of The University Of California | Administration of serine protease inhibitors to the stomach |
RS59060B1 (sr) | 2011-01-05 | 2019-08-30 | Prenatal Int Gmbh | Hipotonična vodena kompozicija sa smanjenim sadržajem hlorida, sa ili bez fosfolipida |
ES2375784B1 (es) | 2011-12-22 | 2013-01-24 | Laboratorios Kin S.A. | Gel de ácido tranexámico |
KR102397379B1 (ko) | 2014-03-25 | 2022-05-13 | 리딩 바이오사이언시즈, 인크. | 자가소화의 치료용의 조성물 |
CN104473864B (zh) * | 2014-11-25 | 2017-02-22 | 陈长潭 | 一种卡络磺钠半固体制剂及其制备方法 |
JP6629877B2 (ja) | 2015-10-30 | 2020-01-15 | 帝人ファーマ株式会社 | 鼻粘膜投与用医薬組成物 |
US11666532B2 (en) | 2018-01-19 | 2023-06-06 | Hyloris Developments Sa | Tranexamic acid oral solution |
JPWO2022065404A1 (sh) * | 2020-09-25 | 2022-03-31 | ||
EP4062919A1 (de) | 2021-03-24 | 2022-09-28 | Prenatal International GmbH | Eine oder mehrere zusammensetzungen auf basis des menschlichen fruchtwassers zur anwendung in einem verfahren zur enteralen ernährung, zur enteralen ernährungsergänzung und/oder zur behandlung und/oder versorgung von kapillararmen schichten |
Family Cites Families (44)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4271143A (en) | 1978-01-25 | 1981-06-02 | Alcon Laboratories, Inc. | Sustained release ophthalmic drug dosage |
CH657779A5 (de) | 1982-10-05 | 1986-09-30 | Sandoz Ag | Galenische zusammensetzungen enthaltend calcitonin. |
AU572815B2 (en) | 1982-12-29 | 1988-05-19 | Armour Pharmaceutical Company | Pharmaceutical calcitonin compositions for intranasal application |
JPS59163313A (ja) * | 1983-03-09 | 1984-09-14 | Teijin Ltd | 経鼻投与用ペプチドホルモン類組成物 |
GB8514090D0 (en) | 1985-06-04 | 1985-07-10 | Sandoz Ltd | Organic compounds |
JPS6034925A (ja) * | 1983-08-04 | 1985-02-22 | Mitsubishi Chem Ind Ltd | 2−ヒドロキシイソフタルアルデヒド類の製造法 |
EP0501523B1 (en) | 1983-11-14 | 1997-04-09 | Columbia Laboratories, Inc. | Bioadhesive compositions |
JPS60123426A (ja) * | 1983-12-07 | 1985-07-02 | Eisai Co Ltd | 経鼻投与用セクレチン製剤 |
JPS60224616A (ja) | 1984-04-24 | 1985-11-09 | Teijin Ltd | 経鼻投与用組成物 |
NZ222907A (en) | 1986-12-16 | 1990-08-28 | Novo Industri As | Preparation for intranasal administration containing a phospholipid absorption enhancing system |
US5179079A (en) | 1986-12-16 | 1993-01-12 | Novo Nordisk A/S | Nasal formulation and intranasal administration therewith |
MY102411A (en) | 1986-12-23 | 1992-06-17 | Ciba Geigy Ag | Nasal solutions |
JPS63303031A (ja) | 1987-05-30 | 1988-12-09 | Nippon Piston Ring Co Ltd | コンプレッサ用ベ−ン |
JPS63303931A (ja) * | 1987-06-05 | 1988-12-12 | Sumitomo Pharmaceut Co Ltd | 経鼻投与用成長ホルモン放出活性物質製剤 |
EP0308181A1 (en) * | 1987-09-14 | 1989-03-22 | Novo Nordisk A/S | Trans-mucosal delivery formulations and a method for preparation thereof |
US5192535A (en) | 1988-02-08 | 1993-03-09 | Insite Vision Incorporated | Ophthalmic suspensions |
US5188826A (en) | 1988-02-08 | 1993-02-23 | Insite Vision Incorporated | Topical ophthalmic suspensions |
US5776493A (en) | 1989-07-14 | 1998-07-07 | Alza Corporation | Oral osmotic device for delivery of nystatin with hydrogel driving member |
DE69014081T2 (de) | 1989-10-31 | 1995-03-30 | Columbia Lab Inc | Mittel zur Feuchthaltung vaginalen Gewebes. |
US5147654A (en) | 1990-07-23 | 1992-09-15 | Alza Corporation | Oral osmotic device for delivering nicotine |
JPH078806B2 (ja) * | 1990-08-16 | 1995-02-01 | 旭化成工業株式会社 | カルシトニン類含有経鼻投与用乳剤 |
GB9102579D0 (en) | 1991-01-24 | 1991-03-27 | Glaxo Group Ltd | Compositions |
GB9103824D0 (en) | 1991-02-23 | 1991-04-10 | Fisons Ag | Formulation |
JPH06510984A (ja) | 1991-04-03 | 1994-12-08 | ガンダーセン メディカル ファウンデーション,リミティド | アスピリンの経皮投与によるトロンボキサンのレベルの抑制 |
US5200195A (en) | 1991-12-06 | 1993-04-06 | Alza Corporation | Process for improving dosage form delivery kinetics |
CA2085871C (en) * | 1991-12-27 | 2002-05-07 | Gerald S. Rork | A controlled release drug dispersion delivery device |
CN1075081A (zh) * | 1992-02-01 | 1993-08-11 | 解放军陆军第44医院 | 复方胶体麻醉剂的配制方法 |
GB9202519D0 (en) * | 1992-02-06 | 1992-03-25 | Glaxo Group Ltd | Medicaments |
JP3047948B2 (ja) | 1992-12-07 | 2000-06-05 | 株式会社ツムラ | ペプチド類経鼻投与用組成物 |
US5340572A (en) | 1993-02-08 | 1994-08-23 | Insite Vision Incorporated | Alkaline ophthalmic suspensions |
US5409703A (en) | 1993-06-24 | 1995-04-25 | Carrington Laboratories, Inc. | Dried hydrogel from hydrophilic-hygroscopic polymer |
JP3781792B2 (ja) | 1993-12-27 | 2006-05-31 | 千寿製薬株式会社 | ジフルプレドナート含有点眼用懸濁液剤 |
JPH07188059A (ja) * | 1993-12-28 | 1995-07-25 | Rohto Pharmaceut Co Ltd | 歯周病治療剤 |
RU2102979C1 (ru) | 1994-07-18 | 1998-01-27 | Панкрушева Татьяна Александровна | Средство для лечения гнойно-воспалительных процессов кожи и слизистых оболочек различной этиологии |
WO1997001337A1 (en) | 1995-06-29 | 1997-01-16 | Mcneil-Ppc, Inc. | The combination of topical nasal antihistamines and topical nasal steroids |
JP3098401B2 (ja) | 1995-07-12 | 2000-10-16 | 株式会社エルティーティー研究所 | 経鼻投与用製剤 |
JP2791317B2 (ja) * | 1995-12-26 | 1998-08-27 | 株式会社三和化学研究所 | 多層フィルム製剤 |
PT943326E (pt) * | 1996-02-27 | 2003-12-31 | Teijin Ltd | Composicao em po para administracao nasal |
JPH09253220A (ja) | 1996-03-26 | 1997-09-30 | Kaajiopeeshingu Res Lab:Kk | 生体内に植え込み可能なリード |
US5976573A (en) * | 1996-07-03 | 1999-11-02 | Rorer Pharmaceutical Products Inc. | Aqueous-based pharmaceutical composition |
RU2111829C1 (ru) | 1996-10-09 | 1998-05-27 | Буркин Сергей Павлович | Способ непрерывного получения тонкой металлической полосы и машина для его осуществления |
US5955097A (en) | 1996-10-18 | 1999-09-21 | Virotex Corporation | Pharmaceutical preparation applicable to mucosal surfaces and body tissues |
TW503113B (en) | 1997-01-16 | 2002-09-21 | Senju Pharma Co | Aqueous suspension for nasal administration |
JP4009355B2 (ja) | 1997-10-02 | 2007-11-14 | 村樫石灰工業株式会社 | 芝草地に発生するコケ・藻類の防除用組成物及び防除方法 |
-
1999
- 1999-04-20 TW TW088106305A patent/TWI243687B/zh active
- 1999-04-21 ES ES99917086T patent/ES2272064T3/es not_active Expired - Lifetime
- 1999-04-21 CN CNB998008850A patent/CN1304052C/zh not_active Expired - Lifetime
- 1999-04-21 US US09/446,276 patent/US6939559B1/en not_active Expired - Lifetime
- 1999-04-21 BR BRPI9906372A patent/BRPI9906372B8/pt not_active IP Right Cessation
- 1999-04-21 AU AU35343/99A patent/AU757772B2/en not_active Expired
- 1999-04-21 UA UA2000010301A patent/UA77640C2/uk unknown
- 1999-04-21 NZ NZ501950A patent/NZ501950A/xx not_active IP Right Cessation
- 1999-04-21 GE GEAP19995184A patent/GEP20022669B/en unknown
- 1999-04-21 HU HU0002512A patent/HU226712B1/hu unknown
- 1999-04-21 EA EA200000060A patent/EA002967B1/ru not_active IP Right Cessation
- 1999-04-21 KR KR1019997012103A patent/KR100686901B1/ko not_active IP Right Cessation
- 1999-04-21 ID IDW991640A patent/ID24818A/id unknown
- 1999-04-21 EP EP99917086A patent/EP0998916B1/en not_active Expired - Lifetime
- 1999-04-21 CZ CZ0460499A patent/CZ298466B6/cs not_active IP Right Cessation
- 1999-04-21 DK DK99917086T patent/DK0998916T3/da active
- 1999-04-21 EE EEP199900589A patent/EE05072B1/xx unknown
- 1999-04-21 SK SK1823-99A patent/SK286101B6/sk not_active IP Right Cessation
- 1999-04-21 SI SI9930931T patent/SI0998916T1/sl unknown
- 1999-04-21 CA CA002294457A patent/CA2294457C/en not_active Expired - Lifetime
- 1999-04-21 PT PT99917086T patent/PT998916E/pt unknown
- 1999-04-21 WO PCT/JP1999/002126 patent/WO1999053899A1/ja active IP Right Grant
- 1999-04-21 JP JP55279399A patent/JP5142420B2/ja not_active Expired - Lifetime
- 1999-04-21 TR TR1999/03193T patent/TR199903193T1/xx unknown
- 1999-04-21 PL PL337534A patent/PL197875B1/pl unknown
- 1999-04-21 DE DE69932905T patent/DE69932905T2/de not_active Expired - Lifetime
- 1999-04-21 AT AT99917086T patent/ATE336986T1/de active
- 1999-09-21 IL IL13361499A patent/IL133614A/en not_active IP Right Cessation
- 1999-10-19 GT GT199900180AK patent/GT199900180AA/es unknown
- 1999-10-19 GT GT199900180A patent/GT199900180A/es unknown
- 1999-10-20 RS YUP-544/99A patent/RS49764B/sr unknown
- 1999-12-15 BG BG104020A patent/BG64919B1/bg unknown
- 1999-12-17 ZA ZA9907727A patent/ZA997727B/xx unknown
- 1999-12-20 IS IS5312A patent/IS2453B/is unknown
- 1999-12-20 NO NO19996323A patent/NO328270B1/no not_active IP Right Cessation
- 1999-12-22 HR HR990402A patent/HRP990402C1/xx not_active IP Right Cessation
-
2002
- 2002-07-24 US US10/201,303 patent/US7235247B2/en not_active Expired - Lifetime
-
2003
- 2003-12-25 JP JP2003430651A patent/JP2004099624A/ja active Pending
-
2005
- 2005-04-11 US US11/102,760 patent/US20050181054A1/en not_active Abandoned
-
2006
- 2006-11-10 CY CY20061101626T patent/CY1105771T1/el unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
YU54499A (sh) | Farmaceutski preparat za primenu na mukozu | |
MX10086A (es) | Un sistema para la administracion de substancias activas no solubles en agua y procedimiento para su preparacion. | |
WO2001058472A3 (en) | Botulinum toxin pharmaceutical compositions | |
CO5271759A1 (es) | Formulacion en solucion que contiene una mezcla de disolventes | |
SE8504945L (sv) | Farmaceutiska kompositioner innehallande antracyklinglykosider | |
CA2336945A1 (en) | Treatment regimen for administration of phenylacetylglutamine, phenylacetylisoglutamine, and/or phenylacetate | |
YU28002A (sh) | Farmaceutska kompozicija koja sadrži ciklesonid za primenu na sluzokoži | |
PT1144420E (pt) | Fosfatidilinositois sulfatados a sua preparacao e a sua utilizacao | |
MY124416A (en) | Pharmaceutical composition for application to mucosa | |
BR0303384A (pt) | Citalopram e seus usos no tratamento de pressão sanguìnea elevada | |
RU95105084A (ru) | Гепатопротекторное средство природного происхождения | |
RU96120655A (ru) | Композиция для профилактики и лечения гриппа и орви | |
AR027614A2 (es) | Compuesto de purina l-nucleosido, composicion farmaceutica que lo comprende y su uso para preparar dicha composicion | |
TH17625EX (th) | สารผสมที่เป็นของเหลวของแกมมาอินเตอร์เฟียรอนที่มีความเสถียร | |
TH56350B (th) | ส่วนประกอบทางเภสัชกรรมที่สำหรับใช้กับเยื่อบุ | |
HUP9801868A2 (hu) | Droloxifén alkalmazása mellrák megelőzésére | |
SV1999000181A (es) | Composicion farmaceutica para ser aplicada a las mucosas ref. er/cr-203.689 |